CSF1R and central nervous system cancer: A recent study in pre-clinical GBM models showed that a specific inhibitor of CSF-1R did not deplete TAM but instead promoted their “re-education” via inhibition of M2-associated genes, resulting in hindered glioma growth and progression [116].